Mark A. Hillman Holdings Activity

Hillman Value Fund Portfolio 13F

Hillman Value Fund has disclosed a total of 19 changes to the portfolio in the latest (2023 Q4) SEC report(s): increased the number of shares of 3, bought 3 totally new, decreased the number of shares of 12 and completely sold out 1 position(s).

What stocks is Mark A. Hillman buying now?

In the recent quarter Mark A. Hillman has bought 6 securities out of which top 5 purchases (by % change to portfolio) are (EL) ESTEE LAUDER COMPANIES-CL A (new buy), (KMX) CARMAX INC (new buy), (PFE) PFIZER INC (new buy), (UMBXX) MONEY MARKET FIDUCIA (added shares +25.72%) and (JWN) NORDSTROM INC (added shares +33.3%).

What does Mark A. Hillman invest in?

Mark A. Hillman's top 5 holdings (by % of portfolio) are (UMBXX) MONEY MARKET FIDUCIA (3.9%), (SPG) SIMON PROPERTY GROUP INC (3.07%), (JWN) NORDSTROM INC (3%), (CRM) SALESFORCECOM INC (2.93%) and (BK) BANK OF NEW YORK MELLON CORP (2.91%).

In the latest report(s) the following changes have been made to the top investments: (UMBXX) MONEY MARKET FIDUCIA (added shares +25.72%) and (JWN) NORDSTROM INC (added shares +33.3%).

2021 Q1 (31 results)
GE
-100.00%
-43,871
-3.16%
$86.40
87.91% $162.35
0.00%
GS
-100.00%
-11,800
-1.80%
$263.71
62.14% $427.57
0.00%
JPM
-100.00%
-24,887
-2.69%
$127.07
52.27% $193.49
0.00%
BAC
-100.00%
-100,000
-1.75%
$30.31
24.81% $37.83
0.00%
JWN
-100.00%
-223,000
-4.03%
$31.21
38.71% $19.13
0.00%
BK
+8.00%
+7,880
+0.22%
$47.29
21.21% $57.32
2.95%
PAA
+8.93%
+27,249
+0.26%
$9.10
96.37% $17.87
3.21%
RTX
+9.93%
+6,157
+0.28%
$77.27
31.24% $101.41
3.05%
DD
+10.34%
+3,090
+0.27%
$77.28
4.62% $73.71
2.86%
MRK
+11.70%
+6,600
+0.29%
$77.09
70.19% $131.20
2.81%
MSFT
+14.71%
+1,325
+0.34%
$235.77
72.34% $406.32
2.66%
CMP
+15.00%
+9,000
+0.33%
$62.72
79.21% $13.04
2.50%
CSCO
+17.78%
+16,000
+0.48%
$51.71
7.45% $47.86
3.17%
GD
+18.32%
+4,800
+0.50%
$181.56
56.65% $284.41
3.26%
BA
+20.88%
+3,800
+0.56%
$254.72
34.35% $167.22
3.24%
KHC
+21.67%
+26,000
+0.60%
$40.00
4.60% $38.16
3.38%
CVS
+22.22%
+14,000
+0.61%
$75.23
10.70% $67.18
3.35%
T
+30.53%
+40,000
+0.70%
$30.27
44.66% $16.75
2.99%
BIIB
+37.88%
+5,000
+0.81%
$279.75
25.33% $208.90
2.95%
BUD
+53.02%
+29,800
+1.08%
$62.85
4.52% $60.01
3.13%
VZ
+59.62%
+38,100
+1.28%
$58.15
31.76% $39.68
3.43%
PFE
+59.80%
+33,320
+1.25%
$36.23
29.89% $25.40
3.33%
BMY
+69.57%
+32,000
+1.17%
$63.13
28.96% $44.85
2.85%
K
+70.52%
+39,700
+1.45%
$63.30
8.80% $57.73
3.52%
META
+72.73%
+8,000
+1.36%
$294.53
50.51% $443.29
3.24%
BDX
+100.00%
+11,640
+1.69%
$243.15
4.77% $231.55
3.38%
UMBXX
+270.12%
+3,347,287
+1.94%
$1.00
-
2.65%
GSK
buy
+120,320
+3.30%
$44.61
7.85% $41.11
3.30%
GOOGL
buy
+32,199
+3.34%
$103.13
66.74% $171.95
3.34%
MMP
buy
+115,000
+2.88%
$43.36
59.13% $69.00
2.88%
AMZN
buy
+32,000
+2.86%
$154.70
16.11% $179.62
2.86%
2020 Q4 (18 results)
NKE
-100.00%
-28,000
-2.66%
$125.54
25.03% $94.12
0.00%
UMBXX
-74.80%
-3,678,575
-2.79%
$1.00
-
0.94%
INTC
+10.00%
+7,200
+0.27%
$49.82
36.01% $31.88
2.99%
GD
+13.91%
+3,200
+0.36%
$148.82
91.11% $284.41
2.96%
WFC
+17.42%
+14,260
+0.53%
$30.18
98.51% $59.91
3.55%
PAA
+18.39%
+52,635
+0.54%
$8.24
116.87% $17.87
3.50%
K
+21.60%
+10,000
+0.47%
$62.23
7.23% $57.73
2.66%
JPM
+22.00%
+4,488
+0.64%
$127.07
52.27% $193.49
0.00%
PFE
+22.09%
+18,000
+0.50%
$36.81
31.00% $25.40
2.78%
VZ
+24.32%
+12,500
+0.56%
$58.75
32.46% $39.68
2.85%
CVS
+26.00%
+13,000
+0.67%
$68.30
1.64% $67.18
3.26%
RTX
+26.51%
+13,000
+0.70%
$71.51
41.81% $101.41
3.36%
XOM
+27.06%
+23,000
+0.72%
$41.22
186.17% $117.96
3.37%
T
+27.18%
+28,000
+0.61%
$28.76
41.76% $16.75
2.86%
EPD
+29.09%
+48,000
+0.71%
$19.59
48.34% $29.06
3.16%
KHC
+31.87%
+19,285
+0.76%
$34.66
10.10% $38.16
3.15%
MRK
+54.95%
+20,000
+1.24%
$81.80
60.39% $131.20
3.50%
BK
buy
+100,000
+3.22%
$42.44
35.06% $57.32
3.22%
49 of 221

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.